Description
EXPRESS REPORT - 4 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 666A40024,554A40354,442A40132,442A40115
Base award description: EXPRESS REPORT - 4 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 442A40035,442A40047,442A40060,554A40103
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-04+$33,681= $33,681
- Mod P000012014-01-03+$22,376= $56,056
- Mod P000022014-02-04+$22,480= $78,537
- Mod P000032014-03-04+$22,846= $101,383
- Mod P000042014-04-02+$28,707= $130,090
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-04 | +$33,681 | $33,681 | EXPRESS REPORT - 4 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 442A40035,442A40047,442A40060,554A40103 |
| Mod P00001· FUNDING ONLY ACTION | 2014-01-03 | +$22,376 | $56,056 | EXPRESS REPORT - 2 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 442A40073,554A40133 |
| Mod P00002· FUNDING ONLY ACTION | 2014-02-04 | +$22,480 | $78,537 | EXPRESS REPORT - 2 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 442A40087,554A40201 |
| Mod P00003· FUNDING ONLY ACTION | 2014-03-04 | +$22,846 | $101,383 | EXPRESS REPORT - 2 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 442A40100,554A40272 |
| Mod P00004· FUNDING ONLY ACTION | 2014-04-02 | +$28,707 | $130,090 | EXPRESS REPORT - 4 PHARMACY ORDERS REPORTED PURCHASE ORDERS REPORTED: 666A40024,554A40354,442A40132,442A40115 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26022F0140 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $100,282 | FY2022 |
| 36C26022F0004 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $454,461 | FY2022 |
| 36C26021F0264 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $130,406 | FY2021 |
| 36C26021F0117 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $75,000 | FY2021 |
| 36C26021F0014 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $220,000 | FY2021 |
| 36C26021F0021 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $355,273 | FY2021 |
Other recipients under 6505 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25916E2832 | GRIFOLS USA LLC | 259-NETWORK CONTRACT OFFICE 19 | $16,949 | FY2016 |
| VA25916P2108 | BAXALTA US INC. | 259-NETWORK CONTRACT OFFICE 19 | $6,212 | FY2016 |
| VA25916P1705 | MCKESSON CORPORATION | 259-NETWORK CONTRACT OFFICE 19 | $11,043 | FY2016 |
| VA25916E2674 | CAREMARK RX, L.L.C. | 259-NETWORK CONTRACT OFFICE 19 | $17,262 | FY2016 |
| VA25916P1805 | BIOLOGICS, INC. | 259-NETWORK CONTRACT OFFICE 19 | $10,442 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25914F1509_3600_V797D30042_3600 · retrieved 2026-09-26.